The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase 2 study of nivolumab with or without ipilimumab combined with stereotactic body radiotherapy in pretreated patients with metastatic biliary tract cancer.
 
Alice Markussen
Employment - Novo Nordisk (I)
Stock and Other Ownership Interests - Novo Nordisk (I)
Research Funding - Bristol-Myers Squibb (Inst); Varian Medical Systems (Inst)
 
Julia S. Johansen
No Relationships to Disclose
 
Finn Ole Larsen
No Relationships to Disclose
 
Susann Theile
No Relationships to Disclose
 
Jane P. Hasselby
No Relationships to Disclose
 
Gro Linno Willemoe
Stock and Other Ownership Interests - Bavarian Nordic; Novo Nordisk; Teva
 
Torben Lorentzen
No Relationships to Disclose
 
Kasper Madsen
No Relationships to Disclose
 
Eva E. Wilken
No Relationships to Disclose
 
Poul F. Geertsen
Research Funding - Bristol Myers Squibb (Inst); Merck KGaA (Inst); MSD Oncology (Inst); Pfizer (Inst); Roche (Inst)
 
Claus Behrens
Research Funding - Brainlab (Inst); Varian Medical Systems (Inst); ViewRay (Inst)
 
Inge Marie Svane
Stock and Other Ownership Interests - IO Biotech
Honoraria - BMS; IO Biotech; MSD; Novartis; Novo Nordisk; Pierre Fabre; Sanofi/Aventis; TILT Biotherapeutics
Consulting or Advisory Role - IO Biotech; MSD; Novartis; Novo Nordisk; Pierre Fabre; TILT Biotherapeutics
Research Funding - Adaptimmune (Inst); Bristol-Myers Squibb (Inst); IO Biotech (Inst); Lytix Biopharma (Inst); TILT Biotherapeutics (Inst)
Travel, Accommodations, Expenses - MSD; Novartis; Pfizer
 
Dorte Nielsen
No Relationships to Disclose
 
Inna Markovna Chen
Consulting or Advisory Role - Amgen
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Genis (Inst); Roche (Inst); Varian Medical Systems (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Celgene; Roche